EGLN3 and lung cancer: The results of a recent study performed in cellular models of lung cancer have shown that the establishment of hypoxia in NSCLC cell lines resulted in a significant decrease in PHD3 protein expression, whereas inhibition of PHD3 resulted in enhanced viability, migration and invasion potential of cancer cells [20].